Skip to content

Clinical trials

Phase 2 Lung Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Country / region: Poland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20052
20071
20084
20091
20101
20121
20131
20141
20161
20171
20181
20221
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Active, not recruiting4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
European Organisation for Research and Treatment of Cancer - EORTC3
Merck Sharp & Dohme LLC3
Eli Lilly and Company2
Incyte Corporation2
Mirati Therapeutics Inc.2
Amgen1
Bristol-Myers Squibb1
CSL Behring1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms24
Carcinoma, Non-Small-Cell Lung17
Neoplasm Metastasis3
Breast Neoplasms2
Carcinoma2
Neoplasms2
Small Cell Lung Carcinoma2
Adenocarcinoma of Lung1
Cachexia1
Colonic Neoplasms1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.